Comparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.
J Thorac Oncol 6(1):115-20 (2011) PMID 21107287
This retrospective analysis sought to investigate the safety, feasibility, and outcomes of platinum doublet therapy in patients aged 70 years or older with advanced non-small cell lung cancer compared with patients younger than 70 years who participated in two randomized phase III trials conducted by the Southwest Oncology Group.
DOI: 10.1097/JTO.0b013e3181fbebfd
Version: za2963e q8za1 q8zb8 q8zc5 q8zdc q8ze7 q8zf1 q8zg2